-
Why Making Dramatic Moves: Cytori Therapeutics (NASDAQ:CYTX), Puma Biotechnology (NYSE:PBYI), Gulfmark Offshore (NYSE:GLF), Nortel Inversora (NYSE:NTL), LightPath Technologies (NASDAQ:LPTH)
On Thursday shares of Cytori Therapeutics, Inc. (NASDAQ:CYTX) closed at $0.69. Company’s sales growth for last 5 years was -12.40%. On May 05, Cytori Therapeutics (NASDAQ: CYTX) announced the pricing of a registered direct public offering of Units, with each Unit consisting of one share of our common stock and one warrant to purchase one…
-
Big Movers: Cytori Therapeutics (NASDAQ:CYTX), BIND Therapeutics (NASDAQ:BIND), Questar Corporation (NYSE:STR), Guidance Software (NASDAQ:GUID), The Cheesecake Factory Incorporated (NASDAQ:CAKE)
On Friday shares of Cytori Therapeutics, Inc. (NASDAQ:CYTX) closed at $0.87. Company’s sales growth for last 5 years was -12.40%. Zacks upgraded shares of Cytori Therapeutics (NASDAQ:CYTX) from a buy rating to a strong-buy rating in a research note released on Friday morning. They currently have $1.40 target price on the stock. BIND Therapeutics, Inc.…
-
Active Stocks to Watch: Cytori Therapeutics (NASDAQ:CYTX), Celsion Corp. (NASDAQ:CLSN), Magellan Petroleum Corporation (NASDAQ:MPET), Layne Christensen Company (NASDAQ:LAYN), Sony Corp (NYSE:SNE)
On Wednesday shares of Cytori Therapeutics, Inc. (NASDAQ:CYTX) closed at $1.15. On 9 April, Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced that the European Commission, acting on the positive recommendation from the European Medicines Agency Committee for Orphan Medicinal Products, has designated Cytori’s ECCS-50 cellular therapeutic as an orphan medicinal product for the treatment of scleroderma. This…
-
Market Movers: California Resources Corporation (NYSE:CRC), Cytori Therapeutics (NASDAQ:CYTX), Rite Aid Corporation (NYSE:RAD), Jinpan International Limited (NASDAQ:JST), Key Tronic Corp. (NASDAQ:KTCC)
On Thursday shares of California Resources Corporation (NYSE:CRC) closed at $8.09. California Resources Corporation (NYSE:CRC) said that, it will host its first quarter financial results conference call on Thursday, April 30th at 5:00 pm Eastern Daylight Time. The Company’s earnings will be released following the market close on the same date. Cytori Therapeutics, Inc. (NASDAQ:CYTX)…
-
Morning Watch List: Halliburton Company (NYSE:HAL), CHC Group (NYSE:HELI), ABM Industries Incorporated (NYSE:ABM), Pfizer Inc. (NYSE:PFE), Cytori Therapeutics (NASDAQ:CYTX)
On Tuesday shares of Halliburton Company (NYSE:HAL) closed at $44.52. Company’s sales growth for last 5 years was 17.50% and EPS growth for next 5 years is recorded as 10.68%. Halliburton Company (NYSE:HAL) which is seeking regulatory approval for its roughly $35 billion purchase of Baker Hughes Inc., plans to sell three drilling business. The…
-
Today’s Hot List: Huntington Bancshares Incorporated (NASDAQ:HBAN), Whitestone REIT (NYSE:WSR), Cytori Therapeutics (NASDAQ:CYTX), Mylan N.V. (NASDAQ:MYL), EMCOR Group Inc. (NYSE:EME)
Huntington Bancshares Incorporated (NASDAQ:HBAN) in last trading activity advanced 0.36% to close at $11.10. Company weekly performance is 0.82% while its quarterly performance stands at 9.47%. Huntington Bancshares Incorporated (NASDAQ:HBAN) is -1.77% away from its 52 week high. Hilliard Lyons began coverage on shares of Huntington Bancshares (NASDAQ:HBAN) in a report issued on Tuesday. The…
-
Momentum Stocks: Cytori Therapeutics (NASDAQ:CYTX), FX Energy Inc. (NASDAQ:FXEN), Tofutti Brands Inc. (NYSEMKT:TOF), Neenah Paper (NYSE:NP), EveryWare Global (NASDAQ:EVRY)
On Monday shares of Cytori Therapeutics, Inc. (NASDAQ:CYTX) closed at $1.32. Company’s sales growth for last 5 years was -12.40%. Shares of Cytori Therapeutics Inc. (NASDAQ:CYTX) jumped after the company said Chinese regulators cleared its regenerative cell technology system. The company said its Cytori Celution System was approved by the State Food and Drug Administration…
-
Stocks in News: Cytori Therapeutics (NASDAQ:CYTX), Paramount Gold and Silver Corp. (NYSEMKT:PZG), Advanced Micro Devices (NASDAQ:AMD), Trina Solar (NYSE:TSL), SunEdison (NYSE:SUNE)
On Monday shares of Cytori Therapeutics, Inc. (NASDAQ:CYTX) closed at $1.32. Company’s sales growth for last 5 years was -12.40%. Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced that its exclusive licensee, Lorem Vascular, has been granted regulatory clearance for the Cytori Celution® System by the State Food and Drug Administration of the People’s Republic of China (CFDA).…
-
Today’s Stocks: Mechel OAO (NYSE:MTL), PDL BioPharma (NASDAQ:PDLI), Cytori Therapeutics (NASDAQ:CYTX), SunEdison (NYSE:SUNE), Alamo Group (NYSE:ALG)
On Tuesday shares of Mechel OAO (NYSE:MTL) closed at $1.24. Company’s sales growth for last 5 years was -2.90%. Mechel OAO (NYSE:MTL) announced having received a nominee’s diploma for employee development in the national “Russian Business Leaders: Dynamics and Responsibility 2014” contest. PDL BioPharma, Inc. (NASDAQ:PDLI) in last trading activity decreased -1.47% to close at…
-
Top Wall Street Stories: Cytori Therapeutics (NASDAQ:CYTX), Fifth Third Bancorp (NASDAQ:FITB), Caesars Entertainment Corporation (NASDAQ:CZR), Landec Corp. (NASDAQ:LNDC), Kindred Healthcare (NYSE:KND)
On Tuesday shares of Cytori Therapeutics, Inc. (NASDAQ:CYTX) closed at $1.18. Company’s sales growth for last 5 years was -12.40%. On March 25, Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced that it will formally launch and showcase its new Celase® GMP enzyme at the 2015 International Society for Cellular Therapy (ISCT) annual meeting on May 27th to…